ATOS - Atossa Genetics Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 518.35M
Enterprise Value 32.23M
Trailing P/E N/A
Forward P/E 1-1.52
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.09
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.13

Trading Information

Stock Price History

Beta (3Y Monthly) 4.28
52-Week Change 338.10%
S&P500 52-Week Change 33.55%
52 Week High 37.3900
52 Week Low 30.8000
50-Day Moving Average 32.1041
200-Day Moving Average 32.4996

Share Statistics

Avg Vol (3 month) 3413.99k
Avg Vol (10 day) 3160.63k
Shares Outstanding 59.13M
Float 9.1M
% Held by Insiders 10.31%
% Held by Institutions 18.70%
Shares Short (Aug 15, 2019) 4312.29k
Short Ratio (Aug 15, 2019) 42.57
Short % of Float (Aug 15, 2019) 43.44%
Short % of Shares Outstanding (Aug 15, 2019) 43.42%
Shares Short (prior month Jul 15, 2019) 4614.71k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 212/1
Last Split Date 3Apr 20, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-59.57%
Return on Equity (ttm)-107.48%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -16.71M
Net Income Avi to Common (ttm)-16.72M
Diluted EPS (ttm)-2.5140
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)17.06M
Total Cash Per Share (mrq)1.87
Total Debt (mrq)75.82k
Total Debt/Equity (mrq)0.43
Current Ratio (mrq)17.80
Book Value Per Share (mrq)1.85

Cash Flow Statement

Operating Cash Flow (ttm)-9.39M
Levered Free Cash Flow (ttm)-4.83M